As of 2024-07-27, the Relative Valuation of Dexcom Inc (DXCM) is 42.37 USD. This relative valuation is based on P/E multiples. With the latest stock price at 64.00 USD, the upside of Dexcom Inc based on Relative Valuation is -33.8%.
The range of the Relative Valuation is 36.51 - 55.50 USD.
| Range | Selected | |
| Trailing P/E multiples | 39.1x - 58.2x | 48.6x |
| Forward P/E multiples | 31.1x - 42.2x | 32.6x |
| Fair Price | 36.51 - 55.50 | 42.37 |
| Upside | -43.0% - -13.3% | -33.8% |
| Date | P/E |
| 2024-07-26 | 67.09 |
| 2024-07-25 | 113.05 |
| 2024-07-24 | 117.34 |
| 2024-07-23 | 117.54 |
| 2024-07-22 | 117.04 |
| 2024-07-19 | 117.05 |
| 2024-07-18 | 116.04 |
| 2024-07-17 | 120.14 |
| 2024-07-16 | 121.66 |
| 2024-07-15 | 118.46 |
| 2024-07-12 | 119.56 |
| 2024-07-11 | 118.10 |
| 2024-07-10 | 116.14 |
| 2024-07-09 | 116.19 |
| 2024-07-08 | 116.33 |
| 2024-07-05 | 119.18 |
| 2024-07-03 | 116.26 |
| 2024-07-02 | 117.92 |
| 2024-07-01 | 117.58 |
| 2024-06-28 | 118.85 |
| 2024-06-27 | 120.07 |
| 2024-06-26 | 118.99 |
| 2024-06-25 | 115.63 |
| 2024-06-24 | 115.91 |
| 2024-06-21 | 122.27 |
| 2024-06-20 | 121.67 |
| 2024-06-18 | 122.27 |
| 2024-06-17 | 122.15 |
| 2024-06-14 | 121.55 |
| 2024-06-13 | 119.30 |
| 2024-06-12 | 122.86 |
| 2024-06-11 | 122.54 |
| 2024-06-10 | 122.20 |
| 2024-06-07 | 121.38 |
| 2024-06-06 | 120.86 |
| 2024-06-05 | 123.78 |
| 2024-06-04 | 122.34 |
| 2024-06-03 | 120.79 |
| 2024-05-31 | 124.50 |
| 2024-05-30 | 124.11 |
| 2024-05-29 | 133.80 |
| 2024-05-28 | 133.53 |
| 2024-05-24 | 133.52 |
| 2024-05-23 | 131.66 |
| 2024-05-22 | 136.83 |
| 2024-05-21 | 137.15 |
| 2024-05-20 | 137.00 |
| 2024-05-17 | 137.70 |
| 2024-05-16 | 138.28 |
| 2024-05-15 | 135.97 |